US Stock MarketDetailed Quotes
TECX Tectonic Therapeutic
- 37.400
- +1.470+4.09%
Close Oct 18 16:00 ET
- 37.400
- 0.0000.00%
Post 20:01 ET
551.07MMarket Cap-12721P/E (TTM)
37.990High35.672Low106.71KVolume36.200Open35.930Pre Close3.96MTurnover1.86%Turnover RatioLossP/E (Static)14.73MShares37.99052wk High3.31P/B214.78MFloat Cap12.12052wk Low--Dividend TTM5.74MShs Float644.400Historical High--Div YieldTTM6.45%Amplitude6.720Historical Low37.151Avg Price1Lot Size
Tectonic Therapeutic Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||
| Gross profit | ||||||
| Operating expense | 7.43%11.42M | 10.11M | 10.63M | 110.31%32.83M | 10.35M | 15.61M |
| Selling and administrative expenses | 133.08%4.35M | --2.09M | --1.87M | 54.89%7.18M | --2.07M | --4.63M |
| -General and administrative expense | 133.08%4.35M | --2.09M | --1.87M | 54.89%7.18M | --2.07M | --4.63M |
| Research and development costs | -19.30%7.07M | --8.02M | --8.77M | 133.71%25.65M | --8.28M | --10.98M |
| Operating profit | -7.43%-11.42M | -10.11M | -10.63M | -110.31%-32.83M | -10.35M | -15.61M |
| Net non-operating interest income expense | 57.61%290K | 60K | 184K | 101.12%5K | 53K | -445K |
| Non-operating interest income | 41.96%318K | --96K | --224K | --149K | --87K | --0 |
| Non-operating interest expense | -30.00%28K | --36K | --40K | -67.64%144K | --34K | --445K |
| Other net income (expense) | -19,150.00%-1.54M | -2K | -8K | -90.95%645K | 0 | 7.13M |
| Gain on sale of security | ---- | ---- | ---- | -90.98%643K | --0 | --7.13M |
| Other non- operating income (expenses) | -19,150.00%-1.54M | ---2K | ---8K | 0.00%2K | --0 | --2K |
| Income before tax | -21.20%-12.67M | -10.05M | -10.46M | -260.48%-32.18M | -10.29M | -8.93M |
| Income tax | ||||||
| Net income | -21.20%-12.67M | -10.05M | -10.46M | -260.48%-32.18M | -10.29M | -8.93M |
| Net income continuous Operations | -21.20%-12.67M | ---10.05M | ---10.46M | -260.48%-32.18M | ---10.29M | ---8.93M |
| Minority interest income | ||||||
| Net income attributable to the parent company | -21.20%-12.67M | -10.05M | -10.46M | -260.48%-32.18M | -10.29M | -8.93M |
| Preferred stock dividends | ||||||
| Other preferred stock dividends | ||||||
| Net income attributable to common stockholders | -21.20%-12.67M | -10.05M | -10.46M | -260.48%-32.18M | -10.29M | -8.93M |
| Basic earnings per share | -21.20%-0.86 | -0.6824 | -0.7096 | -260.48%-2.184 | -0.6985 | -0.6059 |
| Diluted earnings per share | -21.20%-0.86 | -0.6824 | -0.7096 | -260.48%-2.184 | -0.6985 | -0.6059 |
| Dividend per share | ||||||
| Currency Unit | USD | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data